文献速递认知障碍与谵妄衰弱、肌少症与跌倒

养老院入住第一年内胆碱酯酶抑制剂停药的预测因素

Predictors of Cholinesterase Discontinuation during the First Year after Nursing Home Admission.
PubMed 文献 · J Am Med Dir Assoc · 2018-09-24

该研究基于加拿大安大略省2011至2015年新入住养老院的47,851名痴呆老人,其中约三分之一(17,560人)入院时使用胆碱酯酶抑制剂(ChEI),随访一年内有17.7%(3,110人)停药。晕厥、更严重的行为症状、认知障碍、更高衰弱程度及由养老院活跃主治医师处方与停药风险升高独立相关。

要点

  • 入住养老院时约三分之一痴呆老人使用ChEI,一年内停药者占17.7%。
  • 晕厥、严重行为症状、认知障碍、高衰弱及养老院主治医师处方与停药风险升高相关。
  • 高龄、未婚及用药时间较长者停药风险较低。

核心结论

  • 入住养老院时使用ChEI的痴呆老人中,不到五分之一在随后一年内停药。
  • 部分停药预测因素与既往研究和当前临床建议一致,另一些则出乎意料,提示新的ChEI使用驱动因素。

研究设计与样本

  • 基于人群的回顾性队列研究,链接健康行政数据与居民评估工具最小数据集2.0版数据库。
  • 纳入2011至2015年加拿大安大略省新入住养老院的47,851名痴呆老人,平均年龄84.8岁(标准差6.8)。

主要发现

  • 入院时约三分之一(17,560人)使用ChEI,随访期间17.7%(3,110人)停药。
  • 晕厥者停药发生率显著更高(sHR=2.21,95%CI 1.52–3.22)。
  • 更严重行为症状者停药发生率更高(sHR=1.79,95%CI 1.57–2.05)。
  • 认知障碍者停药发生率更高(sHR=1.26,95%CI 1.07–1.48)。
  • 更高衰弱程度者停药发生率更高(sHR=1.19,95%CI 1.04–1.36),养老院活跃主治医师处方者亦更高(sHR=1.28,95%CI 1.14–1.45)。

关键数值与推荐

  • 停药定义为ChEI供应出现30天及以上间隔。
  • 高龄、未婚及用药时间较长与停药发生率显著降低相关。

临床怎么用

  • 对养老院痴呆老人使用ChEI时,应关注晕厥、行为症状、认知障碍及衰弱程度等可能提示停药的因素。
  • 处方医师所在环境(养老院活跃主治医师)与停药风险相关,提示处方模式可能影响用药持续性。

局限性

  • 原文未报告局限性相关内容。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: For persons with dementia, the appropriate duration of cholinesterase inhibitor (ChEI) use remains unclear. We examined patterns of ChEI use during nursing home (NH) transition and the factors associated with discontinuation following admission. DESIGN: Population-based retrospective cohort study using linked health administrative and Resident Assessment Instrument Minimum Dataset, version 2.0 databases. SETTING AND PARTICIPANTS: A total of 47,851 older adults (mean age = 84.8 years, standard deviation = 6.8) with dementia newly admitted to a NH in Ontario, Canada between 2011 and 2015. MEASUREMENTS: ChEI use at admission and during the following year was identified from prescription claims. Resident sociodemographic and health characteristics at admission, including a 72-item frailty index, were derived from the Resident Assessment Instrument Minimum Dataset 2.0. Additional resident and prescriber characteristics were derived from administrative data. Discontinuation was defined as a 30+-day gap in ChEI supply. Multivariable subdistribution hazard models were used to estimate the independent effect of resident frailty and other factors on ChEI discontinuation. RESULTS: Approximately one-third (17,560) of residents with dementia were on a ChEI at admission. Among this group, 17.7% (3110) discontinued use over follow-up. Incidence of discontinuation was significantly higher among residents with syncope [subdistribution hazard ratio, sHR = 2.21, 95% confidence interval, CI (1.52, 3.22)], more severe behavioral symptoms [sHR = 1.79, 95% CI (1.57, 2.05)], cognitive impairment [sHR = 1.26, 95% CI (1.07, 1.48)], higher frailty, [sHR = 1.19, 95% CI (1.04, 1.36)], and a primary prescriber active in the NH [sHR = 1.28, 95% CI (1.14, 1.45)]. A significantly lower incidence was observed for older and unmarried residents and those with a longer duration of use. CONCLUSIONS/IMPLICATIONS: Less than one-fifth of residents on a ChEI at admission discontinued use during the following year. Although some of the predictors of discontinuation align with past research and current clinical recommendations, others were unexpected and point to novel drivers of ChEI use. Future investigations should explore the varied reasons underlying these associations and resident outcomes associated with ChEI discontinuation.

来源:J Am Med Dir Assoc,查看原文。版权归原作者所有。

引用

  1. Maclagan LC, Bronskill SE, Guan J, et al. Predictors of Cholinesterase Discontinuation during the First Year after Nursing Home Admission. J Am Med Dir Assoc. 2018. PMID: 30262440. doi:10.1016/j.jamda.2018.07.020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。